The search terms used were glucagon-like peptide 1 receptor agonist, exenatide, liraglutide, dulaglutide, lixisenatide, semaglutide, albiglutide, taspoglutide, loxenatide, diabetes mellitus, obesity and randomized controlled trial
Driver Growing Incidences of Type 2 Diabetes There is a rise in the incidence rates of type 2 diabetes
Administration of GLP-1 analogs (or DPP-4 inhibitors, which inhibit the degradation of GLP-1), decreased cardiovascular and thrombotic complications in animal models of LPS-induced sepsis
Rao SS, et al
Supportive GLP-1 side effect management often focuses on: Eating smaller meals Staying well-hydrated Paying attention to food choices If side effects start to interfere with daily life, reach out to your clinician to discuss dose and timing
Nature Medicine 2024: s41591-024-03018-2 48-week MRI-PDFF liver fat reduction (51% at 1 mg, 86% at 12 mg)